Detalhe da pesquisa
1.
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
N Engl J Med
; 390(19): 1770-1780, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587249
2.
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation.
Circulation
; 149(12): 932-943, 2024 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264923
3.
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Circulation
; 147(23): 1748-1757, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042255
4.
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Circulation
; 147(16): 1192-1203, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779348
5.
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial.
Am Heart J
; 269: 179-190, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160917
6.
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association.
Arterioscler Thromb Vasc Biol
; 43(10): e404-e442, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706297
7.
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
Eur Heart J
; 44(20): 1807-1814, 2023 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37038327
8.
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Eur Heart J
; 44(4): 293-300, 2023 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36303404
9.
A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
Eur Heart J
; 44(3): 221-231, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35980763
10.
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review.
Curr Opin Lipidol
; 34(6): 243-251, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606894
11.
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease.
Circulation
; 146(15): 1109-1119, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031810
12.
Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Circulation
; 145(4): 242-255, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985309
13.
Acute coronary syndromes.
Lancet
; 399(10332): 1347-1358, 2022 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367005
14.
Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial.
Curr Atheroscler Rep
; 25(3): 85-93, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763180
15.
Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events.
JAMA
; 330(8): 725-735, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606673
16.
Proprotein convertase subtilisin/kexin type 9 inhibition after acute coronary syndrome or prior myocardial infarction.
Curr Opin Lipidol
; 33(3): 147-159, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695614
17.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation
; 144(23): 1845-1855, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710343
18.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
; 143(1): 33-44, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33148016
19.
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials: Insights From the TIMI trials.
Circulation
; 143(7): 685-695, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587654
20.
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 143(7): 673-684, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587659